NutropinAq^®

[ somatropin, recombinant DNA origin, Escherichia coli ]

Description

NutropinAq^® is a liquid formulation of a recombinant human growth hormone administered using the NutropinAq^® Pen.

Active substance

Somatropin, recombinant DNA origin, Escherichia coli

Indications

NutropinAq^® is indicated for:
- Long-term treatment of children with growth failure due to inadequate endogenous growth hormone secretion
- Long-term treatment of growth failure associated with Turner syndrome
- Treatment of prepubertal children with growth failure associated with chronic renal insufficiency up to the time of renal transplantation
- Replacement of endogenous growth hormone in adults with growth hormone deficiency of either childhood or adult-onset etiology. Growth hormone deficiency should be confirmed appropriately prior to treatment.

Further information

Summary of product characteristics

Patient information leaflet